Evidence map›Paper›PMID 17957493›Full record

ArticleJournal of inherited metabolic disease2008

Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group.

B Merinero, B Pérez, C Pérez-Cerdá, A Rincón, L R Desviat, M A Martínez, P Ruiz Sala, M J García, L Aldamiz-Echevarría, J Campos and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Vitamin BJIMD reports · 2017
    Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 5 countries.

B MerineroCentro de Diagnóstico de Enfermedades Moleculares, Centro de Biología Molecular, Facultad de Ciencias, Universidad Autónoma, CIBER de Enfermedades Raras, Madrid, Spain.
B Pérez
C Pérez-Cerdá
A Rincón
L R Desviat
M A Martínez
P Ruiz Sala
M J García
L Aldamiz-Echevarría
J Campos
V Cornejo
M Del Toro
A Mahfoud
M Martínez-Pardo
R Parini
C Pedrón
L Peña-Quintana
M Pérez
M Pourfarzam
M Ugarte
Centro de Investigación Biomédica en Red · ESHospital Clínico San Carlos · ESHospital de Cruces · ESHospital Infantil Universitario Niño Jesús · ESHospital Materno-Infantil · ESHospital Universitario Ramón y Cajal · ESHospital Universitario Virgen del Rocío · ESNewcastle University · GBPetroleum of Venezuela (Venezuela) · VEUniversity of Chile · CLUniversity of Milano-Bicocca · ITVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylmalonic acidaemia (MMA) is a genetic disorder caused by defects in methylmalonyl-CoA mutase or in any of the different proteins involved in the synthesis of adenosylcobalamin. The aim of this work was to examine the biochemical and clinical phenotype of 32 MMA patients according to their genotype, and to study the mutant mRNA stability by real-time PCR analysis. Using cellular and biochemical methods, we classified our patient cohort as having the MMA forms mut (n = 19), cblA (n = 9) and cblB (n = 4). All the mut (0) and some of the cblB patients had the most severe clinical and biochemical manifestations, displaying non-inducible propionate incorporation in the presence of hydroxocobalamin (OHCbl) in vitro and high plasma odd-numbered long-chain fatty acid (OLCFA) concentrations under dietary therapy. In contrast, mut (-) and cblA patients exhibited a milder phenotype with propionate incorporation enhanced by OHCbl and normal OLCFA levels under dietary therapy. No missense mutations identified in the MUT gene, including mut (0) and mut (-) changes, affected mRNA stability. A new sequence variation (c.562G>C) in the MMAA gene was identified. Most of the cblA patients carried premature termination codons (PTC) in both alleles. Interestingly, the transcripts containing the PTC mutations were insensitive to nonsense-mediated decay (NMD).

Indexed as

Genetic Complementation TestAlkyl and Aryl TransferasesAmino Acid Metabolism, Inborn ErrorsBiomarkersCell LineCohort StudiesGenotypeHumansInfantInfant, NewbornMembrane Transport ProteinsMethylmalonic AcidMethylmalonyl-CoA MutaseMitochondrial Membrane Transport ProteinsMitochondrial ProteinsMutationAlkyl and Aryl TransferasesBiomarkerscob(I)alamin adenosyltransferaseMembrane Transport ProteinsMethylmalonic AcidMethylmalonyl-CoA MutaseMitochondrial Membrane Transport ProteinsMitochondrial ProteinsMMAA protein, humanVitamin B 12

Identifiers

PMID17957493
OpenAlexW2141640599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.